Patient Guide: A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05075824
Status: ACTIVE_NOT_RECRUITING
Condition: Sickle Cell Disease
Phase: PHASE2

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Detroit, Michigan
  • • Madison, Mississippi
  • • New York, New York
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) - Join Clinical Trial NCTNCT05075824

How to Join This Clinical Trial - NCTNCT05075824

Learn how to participate in this PHASE2 trial studying an investigational therapy for Sickle Cell Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Sickle Cell Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Sickle Cell Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05075824 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: Contact for availability

Clinical Research Site

Madison, Mississippi 39110 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: Contact for availability

Clinical Research Site

Salvador, Bahia 41253-190 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande Do Sul - Brazil

Status: Contact for availability

Clinical Research Site

Botucatu, São Paulo 18618-970 - Brazil

Status: Contact for availability

Clinical Research Site

Ribeirao Preto, São Paulo 14051-140 - Brazil

Status: Contact for availability

Clinical Research Site

Sao Jose do Rio Preto, São Paulo 15090-000 - Brazil

Status: Contact for availability

Clinical Research Site

Sao Paulo, São Paulo 01323-900 - Brazil

Status: Contact for availability

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Sickle Cell Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships